Table 2. Cancer Site and Standard Morbidity Ratio (SMR; “Cancer Site VTE Risk Score”)* Distribution of Patients with Active Cancer and Venous Thromboembolism: by Case and Control Status.
| Cancer Site | Cases n (%) |
Controls n (%) |
Cancer site VTE risk score (SMR*) |
|---|---|---|---|
| Brain | 18 (3.0) | 14 (2.3) | 47.2 |
| Pancreatic | 52 (8.6) | 13 (2.2) | 42.0 |
| Other digestive | 18 (3.0) | 8 (1.3) | 30.9 |
| Lymphoma | 41 (6.8) | 38 (6.3) | 28.8 |
| Leukemia | 20 (3.3) | 34 (5.6) | 19.8 |
| Stomach | 18 (3.0) | 7(1.2) | 18.2 |
| Multiple myeloma | 8 (1.3) | 15 (2.5) | 14.0 |
| Kidney | 11 (1.8) | 17 (2.8) | 13.9 |
| Lung | 72 (11.9) | 60 (9.9) | 13.0 |
| Ovary† | 17 (5.7) | 16 (5.4) | 13.0 |
| Myeloproliferative neoplasm | 19 (3.2) | 1 (0.2) | 12.6 |
| Bladder | 27 (4.5) | 19 (3.2) | 11.0 |
| Melanoma | 10 (1.7) | 11 (1.8) | 9.7 |
| Breast‡ | 61 (20.6) | 100 (33.8) | 8.6 |
| Other gynecologic‡ | 24 (8.1) | 22 (7.4) | 8.4 |
| Prostate§ | 71 (23.0) | 104 (33.8) | 7.9 |
| Colon/rectal | 75 (12.4) | 74 (12.2) | 7.3 |
| Other cancers combined‡ | 36 (6.0) | 51 (8.4) | ------ |
*
Standard morbidity ratio (SMR; “Cancer site VTE risk score”) among Olmsted County, MN residents with incident venous thromboembolism, 1988-2000; adapted from Petterson, T.M., et al. [34]
†
Women only (296 cases, 296 controls);
§
Men only (308 cases, 308 controls).
‡
Remaining cancers combined (head and neck, liver, other thorax, bone, soft tissue, myelodysplastic syndrome, other genitourinary, eye, misc. cancer [other] with scores of 4.1, 25.9, 0, 0, 5.0, 7.0, 10.6, 26.8, and 9.1, respectively).